Literature DB >> 27670693

PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.

Julia Abelson1, Frank Wagner2, Deirdre DeJean3, Sarah Boesveld3, Franςois-Pierre Gauvin4, Sally Bean5, Renata Axler6, Stephen Petersen7, Shamara Baidoobonso8, Gaylene Pron7, Mita Giacomini3, John Lavis3.   

Abstract

OBJECTIVE: As health technology assessment (HTA) organizations in Canada and around the world seek to involve the public and patients in their activities, frameworks to guide decisions about whom to involve, through which mechanisms, and at what stages of the HTA process have been lacking. The aim of this study was to describe the development and outputs of a comprehensive framework for involving the public and patients in a government agency's HTA process.
METHODS: The framework was informed by a synthesis of international practice and published literature, a dialogue with local, national and international stakeholders, and the deliberations of a government agency's public engagement subcommittee in Ontario, Canada.
RESULTS: The practice and literature synthesis failed to identify a single, optimal approach to involving the public and patients in HTA. Choice of methods should be considered in the context of each HTA stage, goals for incorporating societal and/or patient perspectives into the process, and relevant societal and/or patient values at stake. The resulting framework is structured around four actionable elements: (i) guiding principles and goals for public and patient involvement (PPI) in HTA, (ii) the establishment of a common language to support PPI efforts, (iii) a flexible array of PPI approaches, and (iv) on-going evaluation of PPI to inform adjustments over time.
CONCLUSIONS: A public and patient involvement framework has been developed for implementation in a government agency's HTA process. Core elements of this framework may apply to other organizations responsible for HTA and health system quality improvement.

Entities:  

Keywords:  Framework; Health technology assessment; Patient involvement; Public involvement

Mesh:

Year:  2016        PMID: 27670693     DOI: 10.1017/S0266462316000362

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  27 in total

Review 1.  Public health interventions on prescription redemptions and secondary medication adherence among type 2 diabetes patients: systematic review and meta-analysis of randomized controlled trials.

Authors:  Bayu Begashaw Bekele; Biruk Bogale; Samuel Negash; Melkamsew Tesfaye; Dawit Getachew; Fekede Weldekidan; Tewodros Yosef
Journal:  J Diabetes Metab Disord       Date:  2021-09-02

2.  Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest.

Authors:  Stephanie Harvard; Gregory R Werker
Journal:  Pharmacoeconomics       Date:  2021-05-07       Impact factor: 4.981

3.  Patient and Public Preferences for Treatment Attributes in Parkinson's Disease.

Authors:  Marieke G M Weernink; Janine A van Til; Catharina G M Groothuis-Oudshoorn; Maarten J IJzerman
Journal:  Patient       Date:  2017-12       Impact factor: 3.883

4.  Collaboration Between Researchers and Knowledge Users in Health Technology Assessment: A Qualitative Exploratory Study.

Authors:  Mylène Tantchou Dipankui
Journal:  Int J Health Policy Manag       Date:  2017-08-01

5.  Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions.

Authors:  Meredith Vanstone; Alexandra Cernat; Jeff Nisker; Lisa Schwartz
Journal:  BMC Med Ethics       Date:  2018-04-16       Impact factor: 2.652

6.  EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment.

Authors:  Amy Hunter; Karen Facey; Victoria Thomas; David Haerry; Kay Warner; Ingrid Klingmann; Matthew May; Wolf See
Journal:  Front Med (Lausanne)       Date:  2018-09-06

7.  Characterization of Patient Interest in Provider-Based Consumer Health Information Technology: Survey Study.

Authors:  Joseph Featherall; Brittany Lapin; Alexander Chaitoff; Sonia A Havele; Nicolas Thompson; Irene Katzan
Journal:  J Med Internet Res       Date:  2018-04-19       Impact factor: 5.428

8.  Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.

Authors:  Monika Wagner; Dima Samaha; Roman Casciano; Matthew Brougham; Payam Abrishami; Charles Petrie; Bernard Avouac; Lorenzo Mantovani; Antonio Sarría-Santamera; Paul Kind; Michael Schlander; Michele Tringali
Journal:  Int J Health Policy Manag       Date:  2019-07-01

9.  Patient and Public Involvement in Health Economics and Outcomes Research.

Authors:  Paula K Lorgelly
Journal:  Patient       Date:  2021-03-17       Impact factor: 3.883

10.  Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

Authors:  Rosanne Janssens; Isabelle Huys; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Antonio Ciaglia; Steven Simoens; Hilde Stevens; Meredith Smith; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-04       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.